Network Pharmacology and Molecular Simulation-based Exploration of Abietic Acid against Adenocarcinoma Targeting Hydrolase Enzymes

Background: The protective potential of abietic acid against adenocarcinoma through targeting hydrolase enzymes was not explored, especially using network pharmacology and molecular simulations. Aim: To study the hydrolase enzymes mediated role of abietic acid against adenocarcinoma. Methods: The association of hydrolase enzymes with adenocarcinoma and abietic acid was initially established. A protein-protein interaction (PPI) network was constructed to identify significantly interacting proteins, which were further subjected to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. A bioactive-target-pathway was constructed to characterise pathways involved with abietic acid. Gene expression patterns and survival of hydrolase enzymes in adenocarcinoma were analysed using TIMER 2.0. Molecular docking was performed to assess the binding interactions of abietic acid with PARP1, MMP9, and HDAC1. Molecular dynamics (MD) simulations were carried out for the unbounded state and the ligand-protein complex state of MMP to evaluate structural stability and binding stability. Results: Hydrolase enzymes, including PARP1, MMP9, and HDAC1, were identified as common targets of abietic acid and adenocarcinoma. GO and KEGG enrichment analyses revealed significant enrichment in adenocarcinoma related biological processes, cellular components, molecular functions, and signalling pathways. The bioactive target-pathway validated the association of abietic acid with adenocarcinoma-associated pathways. The gene expression and survival analysis indicated significant associations between hydrolase enzyme expression and decreased survival in adenocarcinoma subtypes. Molecular docking study indicated interactions of abietic acid with PARP1 (-9.4 kcal/mol), MMP9 (-9.4 kcal/mol), and HDAC1 (-9.7 kcal/mol). MD simulation study confirmed the dynamic stability of the abietic acid–MMP9 complex without a significant conformational disruption. Conclusion

View article page

Download PDF